CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer

Background: Although early-stage lung cancer has increased owing to the introduction of screening programs, high recurrence rate remains a critical concern. We aimed to explore biomarkers related to the prognosis of surgically resected non-small-cell lung cancer (NSCLC). Methods: In this retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Yunha, Choi, Chang-Min, Park, Young Soo, Jung, HyunA, Hwang, Hee Sang, Lee, Jae Cheol, Lee, Jung Wook, Lee, Jung Eun, Kang, Jung Hee, Jung, Byung Hun, Ji, Wonjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779436/
https://www.ncbi.nlm.nih.gov/pubmed/35054034
http://dx.doi.org/10.3390/jcm11020341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779436/
https://www.ncbi.nlm.nih.gov/pubmed/35054034
http://dx.doi.org/10.3390/jcm11020341

Ejemplares similares